Sign in
Homepage
Urban News
Celebrity
Crypto
Politics
Technology
Food
Marketing
Music
Travel
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Modal title
Homepage
Urban News
Food
Marketing
Music
Travel
Facebook
Instagram
Linkedin
Mail
X
WhatsApp
Home
World News
Australia
Canada
New Zealand
South Africa
UK
USA
AI Trends
Breaking News
Cybersecurity
Crypto Corner
News Infographics
Podcasts
Latest Podcasts
Technology
Search
Cybersecurity
Evofem Biosciences Secures $706K Funding Through 12% Subordinated Note from HUB Cyber Security
Technology
Nona Biosciences and Lonza Join Forces to Create BBB‑Crossing Single‑Domain Antibodies for CNS Therapy
Related tags
___
_commerce
_custom
_england
_homepage_top_stories
_sensitivecontent
Latest
South African Police Seize Massive Gauteng Drug Lab Worth Millions
Police Bust Alleged Drug Lab, Arrest Five in Krugersdorp
Art Basel × UBS 2026 Survey Unveils Key Art Market Insights
Manhunt for pastor after infant found dead in Atteridgeville
Latest
R300,000 GWM Bakkie Debt Sparks Family Rift
EU Parliament Bars Far-Right Politician’s SA Exhibition
Leveraging AI to Reduce Data Centers’ Environmental Impact
Student Innovators Create AI Education Tools at Minds and Machines Hackathon – @theU
Latest
South African Police Seize Massive Gauteng Drug Lab Worth Millions
Police Bust Alleged Drug Lab, Arrest Five in Krugersdorp
Art Basel × UBS 2026 Survey Unveils Key Art Market Insights
Manhunt for pastor after infant found dead in Atteridgeville
More From Hit Consultant Media
Cybersecurity
Evofem Biosciences Secures $706K Funding Through 12% Subordinated Note from HUB Cyber Security
Press Release
-
July 14, 2026
Key Takeaways Evofem Biosciences secured a $706,304 subordinated promissory note...
Technology
Nona Biosciences and Lonza Join Forces to Create BBB‑Crossing Single‑Domain Antibodies for CNS Therapy
Press Release
-
July 2, 2026
Key Takeaways Nona Biosciences and Lonza have entered a strategic...
ADVERTISMENT
